Experimental and in silico modelling analyses of the gene expression pathway for recombinant antibody and by-product production in NS0 cell lines.
Monoclonal antibodies are commercially important, high value biotherapeutic drugs used in the treatment of a variety of diseases. These complex molecules consist of two heavy chain and two light chain polypeptides covalently linked by disulphide bonds. They are usually expressed as recombinant prote...
Main Authors: | Emma J Mead, Lesley M Chiverton, Sarah K Spurgeon, Elaine B Martin, Gary A Montague, C Mark Smales, Tobias von der Haar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3468484?pdf=render |
Similar Items
-
Effects of Inducers and Antioxidants on Recombinant Protein Production by NS0 Cells Grown in a Chemically Defined Medium
by: Yi-Siang Chen, et al.
Published: (2005) -
Dihydrofolate Reductase-RNA Interference and Unfolded Protein Response for Recombinant Protein Production in CHO and NS0 cells
by: Willy W.L. Hong, et al.
Published: (2007) -
Efficient Plant Production of Recombinant NS1 Protein for Diagnosis of Dengue
by: Mariana Fonseca Xisto, et al.
Published: (2020-10-01) -
Improvement of Recombinant Proteins Production in NS0 Myeloma Cells under Serum-Free Conditions: Effects of Stimulatory Agents and Antioxidants.
by: Shuen-Fang Chang, et al.
Published: (2006) -
A Simple Method for the Design and Development of Flavivirus NS1 Recombinant Proteins Using an In Silico Approach
by: Chulmin Park, et al.
Published: (2020-01-01)